ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

CHB Global X China Biotech Innovations ETF

6.64
0.00 (0.00%)
After Hours
Last Updated: 01:00:00
Delayed by 15 minutes
Name Symbol Market Type
Global X China Biotech Innovations ETF NASDAQ:CHB NASDAQ Exchange Traded Fund
  Price Change % Change Price Bid Price Offer Price High Price Low Price Open Price Traded Last Trade
  0.00 0.00% 6.64 2.67 10.66 0 01:00:00

Rule 8 - Chubb plc

10/07/2003 1:03pm

UK Regulatory


RNS Number:4018N
HBOS PLC
10 July 2003

                                                                    FORM 8.1/8.3

      Lodge with a RIS or Newstrack if appropriate and the Takeover Panel. Use a
    separate form for each class of securities in which dealings have been made.

Date of Disclosure     10/07/03




DISCLOSURE UNDER RULES 8.1(a), 8.1(b)(i) and 8.3 OF THE CITY CODE ON TAKEOVERS
AND MERGERS

Date of dealing     04/07/03




Dealing in (name of company)     CHUBB PLC



1. Class of securities (eg ordinary shares)     GBP ORD



2.
Amount bought                           Amount sold              Price per unit

                                        79,099                   #0.75




3. Resultant total of the same class owned or controlled (and percentage of
class)
13,172,649                                                   1.59%



4. Party making disclosure
HBOS Plc



5. EITHER (a) Name of purchaser / vendor (Note 1)




OR (b) if dealing for discretionary client(s), name of fund management
organisation
HBOS Plc

6. Reason for disclosure (Note 2)




(a) associate of

(i) offeror (Note 3)

NO

(ii) offeree company

NO

Specify which category or categories of associate (1-8 overleaf)




If category (8), explain




(b) Rule 8.3 (ie disclosure because of ownership or control of 1% or more of the
class of relevant securities dealt in)

YES

Signed, for and on behalf of the party named in (4) above




(Also print name of signatory)
Kaeron Heraty

Telephone and Extension number
0207 321 1311 Donna Franks







                      This information is provided by RNS
            The company news service from the London Stock Exchange
END

DCCBDGDRBGBGGXG

1 Year Global X China Biotech I... Chart

1 Year Global X China Biotech I... Chart

1 Month Global X China Biotech I... Chart

1 Month Global X China Biotech I... Chart

Your Recent History

Delayed Upgrade Clock